FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laura Havrilesky

Research Profile

Disorders

Concepts & Ideas

Procedures

Activities & Behaviors

Cost Benefit Analysis

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Rabbie K Hanna; Laura Havrilesky; Robin A Laskey; Micael A Lopez; Marek S Poniewierski; Angeles Alvarez Secord; Aaron Shafer; Linda Van Le; Jeffrey Crawford; David C Dale; Paola A Gehrig; Gary H Lyman
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer.
Lisa M Hess; Bradley J Monk; Lari Wenzel; William E Brady; David E Cohn; Laura Havrilesky; David Cella
Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study.
Angeles Alvarez Secord; Kevin Shuler; Robert Holloway; David M O'Malley; Gloria Broadwater; Nhu-Y Dao; Neil Finkler; Paola A Gehrig; Melissa A Geller; Laura Havrilesky
A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laura Havrilesky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rabbie K Hanna; Laura Havrilesky; Robin A Laskey; Micael A Lopez; Marek S Poniewierski; Angeles Alvarez Secord; Aaron Shafer; Linda Van Le; Jeffrey Crawford; David C Dale; Paola A Gehrig; Gary H Lyman
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer.
Gynecologic oncology 2013;129(1):74-80.
2013: Lisa M Hess; Bradley J Monk; Lari Wenzel; William E Brady; David E Cohn; Laura Havrilesky; David Cella
Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study.
Gynecologic oncology 2013;128(2):175-80.
2013: Angeles Alvarez Secord; Kevin Shuler; Robert Holloway; David M O'Malley; Gloria Broadwater; Nhu-Y Dao; Neil Finkler; Paola A Gehrig; Melissa A Geller; Laura Havrilesky
A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer.
Gynecologic oncology 2013;128(1):65-70.
2012: Robert J Morgan; David M O'Malley; Richard T Penson; Steven W Remmenga; Paul Sabbatini; Joseph T Santoso; Russell J Schilder; Julian Schink; Nelson Teng; Theresa L Werner; Ronald D Alvarez; Deborah K Armstrong; Robert A Burger; Mariana Castells; Lee-May Chen; Larry Copeland; Marta Ann Crispens; Mary A Dwyer; David Gershenson; Heidi Gray; Ardeshir Hakam; Laura Havrilesky; Miranda Hughes; Carolyn M Johnston; Shashikant Lele; Lainie Martin; Ursula Matulonis
Ovarian cancer, version 3.2012.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(11):1339-49.
2012: Lauren E Giugale; Laura Havrilesky; Nicola Di Santo; Mark E Smolkin; Susan C Modesitt
Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.
Gynecologic oncology 2012;127(2):326-31.
2012: Neil T Phippen; Junzo P Chino; Laura Havrilesky; Elizabeth Jewell; Charles A Leath; Jason C Barnett
Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.
Gynecologic oncology 2012;127(2):267-72.
2012: Leigh A Cantrell; David E Cohn; Amanda Fader; Laura Havrilesky; Margaret Liotta; Dominic T Moore; Christa I Nagel; David O'Malley; Peter Rose; Angeles Alvarez Secord; Amy H Wallace; Paola A Gehrig
A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.
Gynecologic oncology 2012;127(1):22-6.
2012: Amanda Fader; Jeffrey M Fowler; Heidi E Frasure; Laura Havrilesky; Emma Rossi; Leigh G Seamon; Angeles Alvarez Secord; Gregory Skafianos; Kristine Zanotti; John F Boggess; David E Cohn; Pedro F Escobar; Paola A Gehrig
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers.
Gynecologic oncology 2012;126(2):180-5.
2012: William J Lowery; Angeles Alvarez Secord; Junzo Chino; Paola A Gehrig; Emily Ko; Laura Havrilesky
Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?
Gynecologic oncology 2012;126(1):12-5.
2012: Angeles Alvarez Secord; Andrew Berchuck; Robert V Higgins; Robert W Holloway; Matthew F Kohler; George S Lewandowski; Lawrence R Nycum; Larry Puls; Fidel A Valea; Laura Havrilesky
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
Cancer 2012;118(13):3283-93.
2012: Laura Havrilesky; Craig F Garfield; Jason C Barnett; David E Cohn
Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer.
Gynecologic oncology 2012;125(3):631-4.
2012: Robin A Laskey; Micael A Lopez; Gary H Lyman; Marek S Poniewierski; Angeles Alvarez Secord; Paola A Gehrig; Rabbie K Hanna; Laura Havrilesky
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.
Gynecologic oncology 2012;125(3):625-30.
2012: Shalini Kulasingam; Laura Havrilesky
Health economics of screening for gynaecological cancers.
Best practice & research. Clinical obstetrics & gynaecology 2012;26(2):163-73.
2012: Junzo P Chino; Ellen Jones; Angeles Alvarez Secord; Andrew Berchuck; Laura Havrilesky
The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer.
International journal of radiation oncology, biology, physics 2012;82(5):1872-9.
2012: Andrew Berchuck; Angeles Alvarez-Secord; Laura Havrilesky
Minimally invasive surgery for endometrial cancer: the horse is already out of the barn.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):681-2.
2011: Robin Pokrzywinski; Larry E Puls; Angeles Alvarez Secord; Laura Havrilesky; Robert V Higgins; Robert W Holloway; Matthew F Kohler; George S Lewandowski; Lawrence R Nycum; Dennis A Revicki
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial.
Gynecologic oncology 2011;123(3):505-10.
2011: Kara A McElligott; Laura Havrilesky; Evan Myers
Preoperative screening strategies for bacterial vaginosis prior to elective hysterectomy: a cost comparison study.
American journal of obstetrics and gynecology 2011;205(5):500.e1-7.
2011: Angeles Alvarez-Secord; Kathleen M Darcy; Laura Havrilesky; Zhiqing Huang; Alan Hutson; Elizabeth Jewell; Paula S Lee; Maurie Markman; Franco Muggia; Susan Murphy
The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
Gynecologic oncology 2011;123(2):314-9.
2011: Patricia A Convery; Nicola Di Santo; Gloria Broadwater; Leigh A Cantrell; Susan C Modesitt; Angeles Alvarez Secord; Laura Havrilesky
Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma.
Gynecologic oncology 2011;123(1):65-70.
2011: Deanna Teoh; Fidel A Valea; Angeles Alvarez Secord; Andrew Berchuck; Paula S Lee; William J Lowery; Evan R Myers; Gregory P Sfakianos; Laura Havrilesky
Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer.
Gynecologic oncology 2011;122(3):467-72.
2011: Jason C Barnett; Andrew Berchuck; Amy E Bondurant; Nicole D Fleming; Laura Havrilesky; Paula S Lee; Angeles Alvarez Secord; Fidel A Valea
Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer.
American journal of obstetrics and gynecology 2011;205(2):143.e1-6.
2011: Elizabeth Jewell; Evan Myers; Kimberly C Nolte; Gregory Samsa; Michael Smrtka; Fidel Valea; Renea Valea; Gloria Broadwater; Debra M Davis; Laura Havrilesky
Utility scores and treatment preferences for clinical early-stage cervical cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(4):582-6.
2011: Laura Havrilesky; Gillian D Sanders; Shalini L Kulasingam; Junzo P Chino; Andrew Berchuck; Jeffrey R Marks; Evan Myers
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
Cancer 2011;117(3):545-53.
2011: Gregory P Sfakianos; Laura Havrilesky
A review of cost-effectiveness studies in ovarian cancer.
Cancer control : journal of the Moffitt Cancer Center 2011;18(1):59-64.
2011: Robert J Morgan; Ronald D Alvarez; Deborah K Armstrong; Barry Boston; Robert A Burger; Lee-May Chen; Larry Copeland; Marta Ann Crispens; David Gershenson; Heidi J Gray; Perry W Grigsby; Ardeshir Hakam; Laura Havrilesky; Carolyn M Johnston; Shashikant Lele; Ursula A Matulonis; David M O'Malley; Richard T Penson; Steven W Remmenga; Paul Sabbatini; Russell J Schilder; Julian C Schink; Nelson Teng; Theresa L Werner
Epithelial ovarian cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(1):82-113.
2011: Nicole D Fleming; Laura Havrilesky; Fidel A Valea; Terrence K Allen; Gloria Broadwater; Amy Bland; Ashraf S Habib
Analgesic and antiemetic needs following minimally invasive vs open staging for endometrial cancer.
American journal of obstetrics and gynecology 2011;204(1):65.e1-6.
2010: Amy H Wallace; Laura Havrilesky; Fidel A Valea; Jason C Barnett; Andrew Berchuck; Evan Myers
Projecting the need for gynecologic oncologists for the next 40 years.
Obstetrics and gynecology 2010;116(6):1366-72.
2010: Jason C Barnett; John P Judd; Jennifer M Wu; Charles D Scales; Evan R Myers; Laura Havrilesky
Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer.
Obstetrics and gynecology 2010;116(3):685-93.
2010: Laura Havrilesky; Thomas Krivak; John W Mucenski; Evan R Myers
Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer.
American journal of obstetrics and gynecology 2010;203(2):160.e1-7.
2010: John P Judd; Nazema Y Siddiqui; Jason C Barnett; Anthony G Visco; Laura Havrilesky; Jennifer M Wu
Cost-minimization analysis of robotic-assisted, laparoscopic, and abdominal sacrocolpopexy.
Journal of minimally invasive gynecology 2010;17(4):493-9.
2009: Elizabeth Jewell; Kathleen M Darcy; Alan Hutson; Paula S Lee; Laura Havrilesky; Lisa A Grace; Andrew Berchuck; Angeles Alvarez Secord
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study.
Gynecologic oncology 2009;115(3):424-9.
2009: Amanda Fader; David Starks; Paola A Gehrig; Angeles Alvarez Secord; Heidi E Frasure; David M O'Malley; Erin R Tuller; Peter G Rose; Laura Havrilesky; Kathleen N Moore; Warner K Huh; Allison E Axtell; Joseph L Kelley; Kristine M Zanotti
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).
Gynecologic oncology 2009;115(2):244-8.
2009: Paula S Lee; Amy Bland; Fidel A Valea; Laura Havrilesky; Andrew Berchuck; Angeles Alvarez Secord
Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2009;13(4):467-72.
2009: Angeles Alvarez Secord; Laura Havrilesky; David M O'Malley; Victoria L Bae-Jump; Nicole D Fleming; Gloria Broadwater; David E Cohn; Paola A Gehrig
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Gynecologic oncology 2009;114(3):442-7.
2009: Laura Havrilesky; Angeles Alvarez Secord; David M O'Malley; Gloria Broadwater; Victoria L Bae-Jump; David E Cohn; Paola A Gehrig
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Gynecologic oncology 2009;114(2):279-83.
2009: Marcus Q Bernardini; Taymaa May; Mahmoud A Khalifa; Amy E Bland; Sharon Nofech-Mozes; Andrew Berchuck; Allan Covens; Laura Havrilesky
Evaluation of two management strategies for preoperative grade 1 endometrial cancer.
Obstetrics and gynecology 2009;114(1):7-15.
2009: Laura Havrilesky; G Larry Maxwell; Evan Myers
Cost-effectiveness analysis of annual screening strategies for endometrial cancer.
American journal of obstetrics and gynecology 2009;200(6):640.e1-8.
2009: Amanda Fader; Richard D Drake; David M O'Malley; Heidi E Gibbons; Warner K Huh; Laura Havrilesky; Paola A Gehrig; Erin Tuller; Allison E Axtell; Kristine M Zanotti
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
Cancer 2009;115(10):2119-27.
2009: Jennifer M Wu; Nazema Siddiqui; Cindy L Amundsen; Evan Myers; Laura Havrilesky; Anthony G Visco
Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
The Journal of urology 2009;181(5):2181-6.
2009: Laura Havrilesky; Gloria Broadwater; Debra M Davis; Kimberly C Nolte; J Cory Barnett; Evan Myers; Shalini L Kulasingam
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
Gynecologic oncology 2009;113(2):216-20.
2009: Angeles Alvarez-Secord; Victoria L Bae-Jump; Laura Havrilesky; Brian Calingaert; Daniel L Clarke-Pearson; John Soper; Paola A Gehrig
Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(3):447-54.
2009: Nikki L Neubauer; Laura Havrilesky; Brian Calingaert; Anuradha Bulusu; Marcus Q Bernardini; Nicole D Fleming; Amy E Bland; Angeles Alvarez Secord
The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.
Gynecologic oncology 2009;112(3):511-6.
2009: Jennifer M Rubatt; Kathleen M Darcy; Alan Hutson; Sarah M Bean; Laura Havrilesky; Lisa A Grace; Andrew Berchuck; Angeles Alvarez Secord
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Gynecologic oncology 2009;112(3):469-74.
2009: Amanda Fader; Christa Nagel; Allison E Axtell; Kristine Zanotti; Joseph L Kelley; Kathleen N Moore; Angeles Alvarez Secord; Christine S Walsh; Warner K Huh; Paola A Gehrig; Heidi Gibbons; Peter G Rose; Laura Havrilesky; Erin Tuller; Richard D Drake; Justin Bottsford-Miller; David M O'Malley
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
Gynecologic oncology 2009;112(3):558-62.
2009: Laura Havrilesky; G Larry Maxwell; John K Chan; Evan Myers
Cost effectiveness of a test to detect metastases for endometrial cancer.
Gynecologic oncology 2009;112(3):526-30.
2009: Amy E Bland; Brian Calingaert; Angeles Alvarez Secord; Paula S Lee; Fidel A Valea; Andrew Berchuck; John Soper; Laura Havrilesky
Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Gynecologic oncology 2009;112(1):150-4.
2008: Laura Havrilesky; Gillian D Sanders; Shalini L Kulasingam; Evan Myers
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Gynecologic oncology 2008;111(2):179-87.
2008: Robert J Morgan; Ronald D Alvarez; Deborah K Armstrong; Barry Boston; Lee-May Chen; Larry Copeland; Jeff Fowler; David K Gaffney; David Gershenson; Benjamin E Greer; Perry W Grigsby; Laura Havrilesky; Carolyn M Johnston; Johnathan M Lancaster; Shashikant Lele; Ursula Matulonis; David O'Malley; Robert F Ozols; Steven W Remmenga; Paul Sabbatini; Julian Schink; Nelson Teng
Ovarian cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(8):766-94.
2008: Laura Havrilesky; Angeles Alvarez Secord; Kathleen M Darcy; Deborah K Armstrong; Shalini Kulasingam
Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4144-50.
2008: Laura Havrilesky; Clark M Whitehead; Jennifer M Rubatt; Robert L Cheek; John Groelke; Qin He; Douglas P Malinowski; Timothy J Fischer; Andrew Berchuck
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
Gynecologic oncology 2008;110(3):374-82.
2008: Paula S Lee; Ryan Bakelaar; C Brennan Fitpatrick; Sarah C Ellestad; Laura Havrilesky; Angeles Alvarez Secord
Medical and surgical treatment of placenta percreta to optimize bladder preservation.
Obstetrics and gynecology 2008;112(2 Pt 2):421-4.
2007: Zhen Zhang; Yinhua Yu; Fengji Xu; Andrew Berchuck; Carolien Van Haaften-Day; Laura Havrilesky; Henk W A de Bruijn; Ate G J van der Zee; Robert P Woolas; Ian J Jacobs; Steven J Skates; Daniel W Chan; Robert C Bast
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.
Gynecologic oncology 2007;107(3):526-31.
2007: Elizabeth Jewell; Shalini L Kulasingam; Evan Myers; Angeles Alvarez-Secord; Laura Havrilesky
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
Gynecologic oncology 2007;107(3):532-40.
2007: Laura Havrilesky; Angeles Alvarez Secord; Shalini L Kulasingam; Evan Myers
Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis.
Gynecologic oncology 2007;107(2):211-8.
2007: Angeles Alvarez-Secord; Laura Havrilesky; Victoria L Bae-Jump; Jeanette Chin; Brian Calingaert; Amy Bland; Teresa Rutledge; Andrew Berchuck; Daniel L Clarke-Pearson; Paola A Gehrig
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Gynecologic oncology 2007;107(2):285-91.
2007: N Calloway Rankins; Angeles Alvarez Secord; Elizabeth Jewell; Laura Havrilesky; John Soper; Evan Myers
Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
Gynecologic oncology 2007;106(2):388-93.
2007: Angeles Alvarez Secord; Kathleen M Darcy; Alan Hutson; Paula S Lee; Laura Havrilesky; Lisa A Grace; Andrew Berchuck
Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 2007;106(1):221-32.
2007: Warner K Huh; J Michael Straughn; A Mariani; Karl C Podratz; Laura Havrilesky; Angeles Alvarez-Secord; Michael A Gold; D Scott McMeekin; Susan C Modesitt; Amy L Cooper; Matthew A Powell; David G Mutch; S Nag; R D Alvarez; David E Cohn
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(4):886-9.
2007: Laura Havrilesky; Angeles Alvarez Secord; Victoria L Bae-Jump; Tina Ayeni; Brian Calingaert; Daniel L Clarke-Pearson; Andrew Berchuck; Paola A Gehrig
Outcomes in surgical stage I uterine papillary serous carcinoma.
Gynecologic oncology 2007;105(3):677-82.
2007: David E Cohn; Emily M Woeste; Stacey Cacchio; Vanna Zanagnolo; Laura Havrilesky; Andrea Mariani; Karl C Podratz; Warner K Huh; Jenny M Whitworth; D Scott McMeekin; Matthew A Powell; Emily Boyd; Gary S Phillips; Jeffrey M Fowler
Clinical and pathologic correlates in surgical stage II endometrial carcinoma.
Obstetrics and gynecology 2007;109(5):1062-7.
2007: Angeles Alvarez Secord; Laura Havrilesky; Michael E Carney; John Soper; Daniel L Clarke-Pearson; Gustavo Rodriguez; Andrew Berchuck
Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer.
International journal of clinical oncology 2007;12(1):31-6.
2007: Laura Havrilesky; Janiel M Cragun; Brian Calingaert; Angeles Alvarez-Secord; Fidel A Valea; Daniel L Clarke-Pearson; Andrew Berchuck; John Soper
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Gynecologic oncology 2007;104(2):401-5.
2007: John Soper; Angeles Alvarez Secord; Laura Havrilesky; Andrew Berchuck; Daniel L Clarke-Pearson
Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(1):298-303.
2006: Evan Myers; Laura Havrilesky; Shalini L Kulasingam; Gillian D Sanders; Kathryn E Cline; Rebecca N Gray; Andrew Berchuck; Douglas C McCrory
Genomic tests for ovarian cancer detection and management.
Evidence report/technology assessment 2006;(145):1-100.
2006: Christopher V Lutman; Laura Havrilesky; Janiel M Cragun; Angeles Alvarez Secord; Brian Calingaert; Andrew Berchuck; Daniel L Clarke-Pearson; John Soper
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Gynecologic oncology 2006;102(1):92-7.
2006: Angeles Alvarez Secord; Paula S Lee; Kathleen M Darcy; Laura Havrilesky; Lisa A Grace; Jeffrey R Marks; Andrew Berchuck
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.
Gynecologic oncology 2006;101(3):390-7.
2006: Evan Myers; Lori A Bastian; Laura Havrilesky; Shalini L Kulasingam; Mishka Terplan; Kathryn E Cline; Rebecca N Gray; Douglas C McCrory
Management of adnexal mass.
Evidence report/technology assessment 2006;(130):1-145.
2005: Laura Havrilesky; Janiel M Cragun; Brian Calingaert; Ingrid Synan; Angeles Alvarez Secord; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Resection of lymph node metastases influences survival in stage IIIC endometrial cancer.
Gynecologic oncology 2005;99(3):689-95.
2005: Angeles Alvarez-Secord; Ellen Jones; Carol A Hahn; William P Petros; D Yu; Laura Havrilesky; John Soper; Andrew Berchuck; Ivan Spasojevic; Daniel L Clarke-Pearson; Leonard R Prosnitz; Mark Dewhirst
Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2005;21(4):333-47.
2005: Janiel M Cragun; Laura Havrilesky; Brian Calingaert; Ingrid Synan; Angeles Alvarez Secord; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3668-75.
2005: John Soper; Laura Havrilesky; Angeles Alvarez Secord; Andrew Berchuck; Daniel L Clarke-Pearson
Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(3):542-8.
2005: John Soper; Angeles Alvarez Secord; Laura Havrilesky; Andrew Berchuck; Daniel L Clarke-Pearson
Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity.
Gynecologic oncology 2005;97(2):596-601.
2005: Laura Havrilesky; Shalini L Kulasingam; David B Matchar; Evan Myers
FDG-PET for management of cervical and ovarian cancer.
Gynecologic oncology 2005;97(1):183-91.
2004: Steven J Skates; Nora K Horick; Yinhua Yu; Feng-Ji Xu; Andrew Berchuck; Laura Havrilesky; Henk W A de Bruijn; Ate G J van der Zee; Robert P Woolas; Ian J Jacobs; Zhen Zhang; Robert C Bast
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4059-66.
2004: Laura Havrilesky; Charles A Leath; Warner K Huh; Brian Calingaert; Rex C Bentley; John Soper; Angeles Alvarez-Secord
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Gynecologic oncology 2004;93(2):429-34.
2004: Johnathan M Lancaster; Holly K Dressman; Regina S Whitaker; Laura Havrilesky; Jonathan Gray; Jeffrey R Marks; Joseph R Nevins; Andrew Berchuck
Gene expression patterns that characterize advanced stage serous ovarian cancers.
Journal of the Society for Gynecologic Investigation 2004;11(1):51-9.
2003: Laura Havrilesky; kathleen M Darcy; Hasnah Hamdan; Roger L Priore; Jorge Leon; Jeffrey Bell; Andrew Berchuck
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3814-25.
2003: Ted M Roth; Angeles Alvarez Secord; Laura Havrilesky; Ellen Jones; Daniel L Clarke-Pearson
High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease.
Gynecologic oncology 2003;91(1):258-60.
2003: Laura Havrilesky; Bercedis L Peterson; Damla K Dryden; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Predictors of clinical outcomes in the laparoscopic management of adnexal masses.
Obstetrics and gynecology 2003;102(2):243-51.
2003: Ellen Jones; Thaddeus V Samulski; Mark Dewhirst; Angeles Alvarez-Secord; Andrew Berchuck; Daniel L Clarke-Pearson; Laura Havrilesky; John Soper; Leonard R Prosnitz
A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.
Cancer 2003;98(2):277-82.
2003: Laura Havrilesky; Terence Z Wong; Angeles Alvarez Secord; Andrew Berchuck; Daniel L Clarke-Pearson; Ellen Jones
The role of PET scanning in the detection of recurrent cervical cancer.
Gynecologic oncology 2003;90(1):186-90.
2003: Laura Havrilesky; Angeles A Alvarez; Robyn A Sayer; Johnathan M Lancaster; John Soper; Andrew Berchuck; Daniel L Clarke-Pearson; Gustavo Rodriguez; Michael E Carney
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.
Gynecologic oncology 2003;88(1):51-7.
2001: Carolien Van Haaften-Day; Y Shen; F Xu; Yinhua Yu; Andrew Berchuck; Laura Havrilesky; Henk W A de Bruijn; Ate G J van der Zee; Robert C Bast; Neville F Hacker
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
Cancer 2001;92(11):2837-44.
2001: Laura Havrilesky; Angeles A Alvarez; Regina S Whitaker; Jeffrey R Marks; Andrew Berchuck
Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Gynecologic oncology 2001;83(3):491-500.
2001: Laura Havrilesky; CP McMahon; Edward K Lobenhofer; Regina Whitaker; Jeffrey R Marks; Andrew Berchuck
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Journal of the Society for Gynecologic Investigation 2001;8(2):104-13.
1995: Laura Havrilesky; A Elbendary; J A Hurteau; Regina S Whitaker; Gustavo Rodriguez; Andrew Berchuck
Chemotherapy-induced apoptosis in epithelial ovarian cancers.
Obstetrics and gynecology 1995;85(6):1007-10.
1995: Laura Havrilesky; J A Hurteau; Regina S Whitaker; A Elbendary; S Wu; Gustavo Rodriguez; Robert C Bast; Andrew Berchuck
Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.
Cancer research 1995;55(4):944-8.
1994: A Elbendary; Andrew Berchuck; P Davis; Laura Havrilesky; Robert C Bast; J Dirk Iglehart; Jeffrey R Marks
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(12):1301-7.
1994: Andrew Berchuck; A Elbendary; Laura Havrilesky; Gustavo Rodriguez; Robert C Bast
Pathogenesis of ovarian cancers.
Journal of the Society for Gynecologic Investigation 1994;1(3):181-90.